Invezz

Floki floods Times Square New York with ads on a 3-month marketing campaign

Floki floods Times Square New York with ads on a 3-month marketing campaign
Newton Gitonga
Mar 08, 2024, 05:03 AM
  • Floki to dominate the heart of New York for 93 days.
  • FLOKI adverts will take over the massive Times Square LED screen starting next week.
  • That comes after the coin’s staggering 300% price surge last week.

In a groundbreaking development, meme token Floki Inu (FLOKI) unveiled plans to dominate New York with a massive marketing movement.

The project will launch this extensive campaign in Times Square starting 15 March.

According to the announcement, the three-month promotion will exhibit FLOKI on the 56 by 29 feet digital screen in Times Square purposefully beside the Nasdaq commercial.

The impressive billboard covered a massive viewing space, 1,624 square feet, making the altcoin visible to thousands of daily Time Square visitors.

The digital screen will showcase FLOKI’s attractive ten-second ads for 20 hours per day (4 times per hour) throughout the 93-day campaign.

Times Square remains a vital hub for marketing, with over 300,000 daily guests and 50 million annual visitors, making it among the busiest centers in the US.

The immense marketing in New York matches Floki’s goal of attracting the attention of massive audiences globally.

Floki price outlook

FLOKI traded at $0.000183 at press time, up nearly 40% within the last 24 hours. The altcoin maintains robust momentum following the recent memecoin-driven broad market revival.

The meme token gained over 300% and 600% on its 7-day and monthly price charts.

The massive marketing in Times Square will further solidify Floki’s as a legitimate asset in the memecoin and cryptocurrency markets.

Further, the promotion will coincide with the anticipated halving-catalyzed bull rally, highlighting the team’s dedication to keeping FLOKI at the industry’s forefront.

Further, the Floki will remain on investor radar as the community plans significant token burns.